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Computational analysis of gene expression data from microarrays has been useful for medical diagnosis and
prognosis. The ability to analyze such data at the level of biological modules, rather than individual genes, has been
recognized as important for improving our understanding of disease-related pathways. It has proved difficult,
however, to infer pathways from microarray data by deriving modules of multiple synergistically interrelated genes,
rather than individual genes. Here we propose a systems-based approach called Entropy Minimization and Boolean
Parsimony (EMBP) that identifies, directly from gene expression data, modules of genes that are jointly associated with
disease. Furthermore, the technique provides insight into the underlying biomolecular logic by inferring a logic
function connecting the joint expression levels in a gene module with the outcome of disease. Coupled with biological
knowledge, this information can be useful for identifying disease-related pathways, suggesting potential therapeutic
approaches for interfering with the functions of such pathways. We present an example providing such gene modules
associated with prostate cancer from publicly available gene expression data, and we successfully validate the results
on additional independently derived data. Our results indicate a link between prostate cancer and cellular damage
from oxidative stress combined with inhibition of apoptotic mechanisms normally triggered by such damage.
Citation: Varadan V, Anastassiou D (2006) Inference of disease-related molecular logic from systems-based microarray analysis. PLoS Comput Biol 2(6): e68. DOI: 10.1371/
journal.pcbi.0020068
Introduction
The expression levels of thousands of genes, measured
simultaneously using DNA microarrays, provide information
useful for medical diagnosis and prognosis [1,2]. However,
their ability to provide signiﬁcant help towards devising
therapeutic approaches has not yet been demonstrated. This
failure can be partly attributed to the fact that traditional
gene selection techniques typically end up producing a ‘‘list
of genes’’ that are correlated with disease, without providing
insights into the mutual interrelationships of these genes.
Gene selection techniques from microarray analysis are
often based on individual gene ranking depending on a
numerical score measuring the correlation of each gene with
particular disease types. The expression levels of the highest-
ranked genes tend to be either consistently higher in the
presence of disease and lower in the absence of disease, or
vice versa. Such genes usually have the property that their
joint expression levels corresponding to diseased tissues and
the joint expression levels corresponding to healthy tissues
can be cleanly separated into two distinct clusters. These
techniques are therefore convenient and powerful for
classiﬁcation purposes between disease and health, or
between different disease types, but they are incompatible
with a systems biology viewpoint, because they do not identify
systems of synergistically interacting genes, whose joint
expression state predicts disease. Rather, microarray cluster-
ing techniques tend to produce clusters of co-regulated
genes.
Sophisticated machine learning classiﬁcation approaches,
in which a hypersurface on a high-dimensional space serves as
a classiﬁcation boundary separating the gene expression
points into classes of tissues, have also been successfully used.
Certain nonlinear transformations are typically used to
deﬁne the shape of the hypersurface, but the performance
of the algorithms is limited by the ability to identify and use
the optimum such transformation. Furthermore, the set of
selected genes is typically not combined with an easily
interpretable interrelationship among its members, which
could otherwise provide biological insight about the com-
bined role of these genes.
To address such problems, several efforts have recently
been made to analyze expression data at the level of
biological modules, rather than individual genes [3–9].
However, it has proved difﬁcult, so far, to infer modules of
multiple synergistically interrelated genes directly from
microarray data.
In this paper, we present a systems-based approach
(Entropy Minimization and Boolean Parsimony [EMBP]) that
identiﬁes modules of genes jointly associated with disease
from gene expression data. The technique also produces a
simple logic function connecting the combined expression
levels in each gene module with the presence of disease.
Roughly speaking, the goals of EMBP analysis are, ﬁrst, to
identify the smallest module of genes whose joint expression
levels can predict the presence of disease with high accuracy,
and, second, to identify the simplest logic function connect-
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analysis on a prostate cancer dataset [10], and validated the
resulting gene modules and logic functions on a different
dataset [11].
Results
Binarization of Gene Expression Data
We ﬁrst binarize microarray expression data into two
levels. Although the EMBP methodology can be generalized to
account for multiple expression levels, binarization of
expression data simpliﬁes the presentation of the concepts
in this paper and provides simple logical functions connect-
ing the genes within the found modules.
Rather than independently binarizing each gene’s expres-
sion level, which would be more appropriate for an individual
gene ranking approach, we chose to use single thresholds for
all genes. This approach is consistent with the fact that we
seek to ﬁnd global interrelationships among genes and that
the microarray data have already been normalized across all
tissues and all genes. Therefore, a choice of high threshold
will identify the genes that are ‘‘strongly’’ expressed, while a
choice of a low threshold will identify the genes that
expressed even ‘‘weakly.’’ We performed EMBP analysis
across several thresholds and we focused on the threshold
choices that provided best performance, as described in the
following sections.
Entropy Minimization
Following binarization, each gene is assumed to be either
expressed or not expressed in a particular tissue, and we also
assume that there are two types of tissues, either healthy ones
or tissues suffering from a particular disease. The latter
assumption can also be generalized to include more than two
types of tissues, or modiﬁed to be used for classiﬁcation
among several disease types.
Thus, given M genes and K tissues, an M 3 K binary
‘‘expression matrix’’ E is deﬁned so that E(i,j) is 1 if gene i is
expressed in tissue j, and 0 otherwise. Furthermore, a K-
vector c is deﬁned so that c(j) is 1 if tissue j is diseased and 0 if
it is healthy. For each gene module of size n, there are 2
n
possible gene expression states, and for each state S we can
count the number N0(S) of times that the state appears in a
healthy tissue, and the number N1(S) of times that it appears
in a diseased tissue. We can then create a table with 2
n rows
corresponding to the gene expression states, which we refer
to as the ‘‘state-count table’’ in which each row contains the
two counts N0 and N1 for the corresponding state. Table 1
shows two examples of such state-count tables for n ¼ 4.
We ﬁrst address the following problem:
Given a number n, identify the set of n genes whose
combined expression levels predict the presence or absence
of disease with minimum uncertainty.
We refer to this problem as the ‘‘entropy minimization’’
problem, because we quantify the uncertainty with the
information-theoretic measure known as conditional entropy
[12] after creating a probabilistic model in which probabil-
ities are equal to relative frequencies derived from the counts
N0(S) and N1(S), so that the presence of disease and the gene
expression states are random variables.
In the following, we deﬁne the conditional entropy and
explain in what sense it measures uncertainty. Given a
discrete random variable satisfying a probability distribution
fpig,t h ee n t r o p y 
X
i
pilog2pi is, in rough terms, the
‘‘average length of the shortest description’’ of the value of
the variable [12]. More formally, if we have a sequence of
independently drawn symbols, all of which obey an identical
probability distribution, then it is a result proven by Shannon
[13] that the entropy of that probability distribution
measures the minimum average number of bits per symbol
required to describe their values. Similarly, the conditional
entropy of a random variable, given another variable, is
deﬁned as the expected value of the entropies of the
conditional distributions, averaged over the conditioning
random variable [12], and it measures the average length of
the shortest description of the value of one random variable
given the value of another. For our purposes, assume that the
binary random variable C describes the presence or absence
of a particular disease, and that S is the random variable
(binary n-vector) describing the expression state of a
particular gene set of size n. The quantity that we wish to
minimize is the conditional entropy, HðCjSÞ,o fC given S.
Speciﬁcally, using the counts N0 and N1, we deﬁne
PðSÞ¼
N0ðSÞþN1ðSÞ
K
ð1Þ
as the probability of encountering expression state S in a
tissue chosen at random, and
QðSÞ¼
N0ðSÞ
N0ðSÞþN1ðSÞ
ð2Þ
as the probability of disease in a tissue, given that its
expression state is S, where Equation 2 is applied for the
states that have been encountered at least once.
If we know the expression state S for a particular tissue,
then the uncertainty of determining whether or not disease
exists in that tissue is measured by the entropy HðQðSÞÞ,
where the function H is deﬁned by
HðqÞ¼  qlog2ðqÞ ð 1   qÞlog2ð1   qÞð 3Þ
Note that the function H(q) becomes close to 0 for values of q
that are close to either 0 or 1, and takes a maximum value of 1
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Entropy Minimization and Boolean Parsimonyfor q ¼ 0.5, which is consistent with its interpretation as
uncertainty. The average overall uncertainty of determining
whether or not disease is present is then measured by the
conditional entropy of the presence of disease given the
expression state for the gene set:
X
PðSÞHðQðSÞÞ ð4Þ
where the summation is over all 2
n states S with P(S) . 0.
Again, this formula is consistent with the intuitive interpre-
tation of uncertainty, because it becomes small whenever the
probabilities Q(S) become close to either 0 or 1 for the more
frequently encountered states.
Finally, to ensure that the range of possible values for the
conditional entropy extends from 0 to 1, we normalize by
dividing by HðQnullÞ, the entropy corresponding to the
probability of disease in a randomly chosen tissue. (In the
case of the prostate data that we use, this probability is equal
to 52/102). For simplicity, in the sequel we will often refer to
the normalized conditional entropy as just ‘‘entropy.’’
The conditional entropy, as deﬁned above, depends on the
counts N0 and N1 for the 2
n states. Its interpretation as a
measure of uncertainty is illustrated in the example of Table
1, which contains two state-count tables that were created
using the binarized expression matrix for the 102 prostate
tissues used in this paper, and a threshold of 15. The state-
count table on the left corresponds to a choice of four genes
a, b, c, and d, selected at random. The resulting value of the
normalized conditional entropy of 0.951 is typical for
random choices of gene sets. On the other hand, the state-
count table on the right corresponds to the gene set for which
we found the minimum normalized conditional entropy of
0.088, consisting of genes a: COL4A6, b: CYP1B1, c: SERPINB5,
and d: GSTP1, to be discussed later in this paper. In this latter
gene set choice, as shown in Table 1, the reduced entropy is
manifested by the fact that the statistics are skewed for nearly
all states. For example, all 13 tissues corresponding to state
0101 are cancerous, and all 12 issues corresponding to state
1001 are healthy.
The entropy minimization problem consists of identifying
the gene set with the minimum conditional entropy, as
deﬁned above, among all subsets of size n of the full set of M
genes. The number of these subsets is equal to ð
M
n
Þ and
becomes large for n   3, making the exhaustive search
method impractical. As explained in the Materials and
Methods section below, however, this problem can easily be
addressed using heuristic search optimization methods.
If the conditional entropy for a particular gene set is found
to be exactly 0, this implies that the joint expression levels of
the members of that gene module determine the existence of
disease with absolute certainty under the assumption of the
probabilistic model derived from the relative frequencies.
This happens whenever, for all 2
n states in the corresponding
state-count table, at least one of the counts N0 and N1 is 0. In
our experiments, we have found that when this occurs, a large
number of states are only encountered once or twice. We
cannot make any reliable association of disease based on
these rarely encountered states, and including them in our
model will result in ‘‘overﬁtting,’’ so we treat them as noise
and ignore them, in favor of the states which predominantly
correspond to disease. Our deﬁnition for such states is that
they have been encountered at least three times and that the
number of corresponding diseased tissues is at least four
times larger than the count of corresponding healthy tissues,
i.e., N1   3 and N1   4N0. Therefore, whenever we ﬁnd the
entropy for a gene set to be exactly 0, we decrease the size of
the gene set by 1, and select the minimum-entropy gene set of
that size. Thus, the output of the EMBP analysis contains a
gene module for which the conditional entropy is close, but
not equal, to 0.
Calculating the conditional entropy of a particular set of
genes of length n involves evaluating the counts N0(S) and
N1(S) for each of the 2
n states. However, the number of states
for which these counts are non-zero cannot be larger than the
Table 1. Two Examples of State-Count Tables and the Corresponding Normalized Conditional Entropies
Example 1 Example 2
abcdN0 N1 abcdN0 N1
00000 0 00000 1 4
00010 0 00015 0
00100 0 00108 0
00110 0 00112 0
01000 0 01001 1 9
01011 0 01010 1 3
01101 2 2 1 01100 2
01111 0 1 0 01110 1
10000 0 10004 0
10012 1 10011 20
10100 0 10104 0
10110 0 10116 0
11000 0 11001 3
11018 3 11012 0
11102 1 11100 0
11111 5 1 6 11115 0
H ¼ 0.951 H ¼ 0.088
H indicates the normalized conditional entropy value.
DOI: 10.1371/journal.pcbi.0020068.t001
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Entropy Minimization and Boolean Parsimonynumber K of tissues. Thus the computational cost of
calculating the entropy of a gene set remains bounded
regardless of the size of the gene set.
Boolean Parsimony
Once a gene module has been identiﬁed, and the
expression states for that module that are predominantly
associated with disease have been determined as described
above, we then address the following problem: Given the gene
expression states associated with disease, ﬁnd the simplest
logical rule that connects the expression levels in the gene
module with the presence of disease.
We refer to this problem as the ‘‘Boolean parsimony’’
problem, because the logical rule will be identiﬁed by the
‘‘most parsimonious Boolean function.’’ Our deﬁnition for
this logic function is one containing the operators AND, OR
and NOT, which minimizes a ‘‘cost,’’ deﬁned as the total
number of logic variables appearing in the expression. In
Boolean algebra [14], each logic variable can take the value of
either 0 (false) or 1 (true), the operator AND corresponds to
multiplication, and the operator OR corresponds to addition.
We use the symbol of prime (9) following the logic variable to
designate the operator NOT. For example, abþa9b9þab9
means (a AND b) OR [(NOT a) AND (NOT b)] OR [a AND
(NOT b)] and the ‘‘cost’’ (as deﬁned above) of this Boolean
function is 6, because each of the variables a and b appears
three times. This Boolean expression happens to be logically
equivalent to aþb9, meaning: a OR (NOT b). The latter
expression is more parsimonious than the former, because its
‘‘cost’’ is equal to 2, as each of the letters a and b appears
once.
The reason for the need of Boolean parsimony is that the
biological role of each gene becomes more immediately clear
if the Boolean expression contains the corresponding logic
variable either once or only a few times. We selected the
above deﬁnition of Boolean parsimony because the logic
functions AND, OR, and NOT often have straightforward
potential biological interpretations.
The problem is easily solved manually when the size of the
gene set is less than 5, as in the examples of this paper, using
Karnaugh map logic design methodology [15] (Figure 1).
Otherwise, Boolean minimization programs such as Espresso
[16] can be used. Most of them retain the ‘‘sum of products’’
structure of the Boolean expression, but further minimiza-
tion is desirable and possible using heuristic algorithms [17].
The computational cost of Boolean Parsimony is insignif-
icant compared to that of Entropy Minimization. For
example, Espresso [16] takes less than a minute on a standard
Pentium III processor running at 3 GHz for Boolean
functions involving many tens of variables. The BDS
algorithm [17] used to ﬁnd the most parsimonious Boolean
function also takes less than a minute for functions having
many tens of Boolean variables.
Prostate Cancer EMBP Analysis
We used two different prostate cancer datasets. The ﬁrst
prostate cancer microarray expression data [10] contain gene
expression proﬁles for 102 prostate tissues, of which 52 were
cancerous and 50 were healthy and is available in the public
domain from http://www-genome.wi.mit.edu/MPR/prostate.
The gene expression proﬁles in scaled average difference
units were produced using HG-U95A Affymetrix microarrays
with probes for 12,600 genes (Affymetrix, Santa Clara,
California, United States). This dataset will henceforth be
referred to as the ‘‘EMBP dataset,’’ because we used it to
apply EMBP analysis. A second independently derived data-
set, also containing scaled average difference units referring
to 34 tissue samples of which 25 were cancerous and nine
were healthy was also obtained from the public domain [11]
(http://www.gnf.org/cancer/prostate) and used for validating
the gene modules and logic functions estimated over the
EMBP dataset. This latter dataset will be referred to as the
‘‘validation dataset.’’
Gene module and Boolean function identiﬁcation using the
EMBP dataset. Each threshold choice for binarizing the
continuous-valued data of the EMBP dataset will produce
potentially different results. The ‘‘optimum’’ threshold can be
deﬁned and evaluated as the one that yields the minimum
overall entropy. In our case, we found that this would be
equal to 60. However, EMBP analysis is not meant to produce
a unique gene set as its output. Rather, it can reveal a rich
content of information from the microarray data by using
different threshold choices. The combined information
resulting from several such gene sets can further help provide
insight into related pathways.
We used several thresholds ranging from  30 to 225 in
steps of 15 and estimated the minimum entropy gene
modules for each of them. For each threshold value we
considered gene modules of size n ¼ 1, 2, 3, and 4. For n ¼ 4,
we found that the entropy values occasionally went down to
precisely 0 due to overﬁtting. On the other hand, we found
several gene sets of size 3 with entropy values less than 0.20,
which is low—note that H(0.97) ¼ 0.20, meaning that if the
conditional entropy is 0.20, then, on the average, each state is
associated with either cancer or health with probability 97%.
Therefore, we selected n ¼ 3 to be the number of genes
included in these gene modules. Our results of are shown in
Figure 2A. The thresholds for which the minimum entropy
values were below 0.20 for n¼3 are 30, 45, 60, 75, and 90. The
minimum entropy gene modules for these thresholds along
with their entropies are listed in Table 2. In the following, we
use the ofﬁcial gene symbols, and Table 3 contains a legend
Figure 1. Example of Estimating the Boolean Function for a Gene
Module
The state-count table for a set of three genes is used to create the 432
table shown on the right, known as a ‘‘Karnaugh map.’’ The binary
coordinates in the rows and columns of Karnaugh maps are arranged
according to the ‘‘Gray code’’ (consecutive coordinates differ by one bit
only) for easier derivation of the logical function. Each entry of the
Karnaugh map corresponds to one of the states and the numbers shown
are equal to the counts N0 and N1 for that state. In this example, there
are three entries (010, 110, 111) identified as predominantly associated
with a particular disease. States 010 and 110 can be jointly described by
the function bc9. Similarly, states 110 and 111 can be jointly described by
the function ba. The overall Boolean function describing the area
highlighted by bold lines in the Karnaugh map is bc9þba ¼ b(c9þa).
DOI: 10.1371/journal.pcbi.0020068.g001
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Entropy Minimization and Boolean Parsimonywith the corresponding accession numbers, aliases, and brief
gene descriptions.
To evaluate the signiﬁcance of these minimum entropy
values, we performed entropy minimization over ten random
permutations of the tissue class labels. In other words, while
keeping the number of healthy and cancerous tissues
constant to 50 and 52, respectively, we randomly assigned
healthy (0) and cancerous (1) labels to the individual tissue
proﬁles. The entropy minimization algorithm was performed
on the randomly permuted data, and the average minimum
entropies for n ¼ 3 were estimated for the thresholds 30, 45,
60, 75, and 90 for the same expression matrix of the EMBP
dataset. The estimated averages of the entropies are shown in
the heavy black line in Figure 2B. Notably, the entropy values
for the randomly permuted data for n ¼ 3 are much higher
than those estimated on the actual dataset, and even
Figure 2. Minimum Entropy across Different Thresholds
(A) Estimates of the minimum entropy values for gene modules of size n ¼ 1, 2, and 3 across various thresholds.
(B) Minimum entropy values for subset of thresholds (colored lines) along with the estimated means of the entropies over randomly permuted data for
n ¼ 3 (black line).
DOI: 10.1371/journal.pcbi.0020068.g002
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with n ¼ 2, indicating that the gene modules identiﬁed by
entropy minimization on the actual data have real biological
meaning, rather than being due to chance. To further
emphasize this fact, we performed entropy minimization
over 40 random permutations of the tissue class labels using
the E matrix for threshold 60, chosen because it yields the
lowest overall entropy. We observed that the 40 entropy
values derived from the permuted data consistently ﬁt a
normal distribution using any of the chi-square, Lillie and
Geary tests [18]. The mean and standard deviation of the
entropy values were 0.4557 and 0.0433, respectively. Using
these statistics, we estimated the p-value of the minimum
entropy on the actual data, deﬁned as the probability of the
minimum entropy being not more than 0.11587 purely by
chance to be extremely small, equal to 2 3 10
 15.
We then estimated the most parsimonious Boolean
functions for these ﬁve gene modules, which were selected
because the corresponding thresholds are close to each other
and spread around the ‘‘optimum’’ one, equal to 60, as
mentioned above. Figure 3 contains the Karnaugh maps from
which the functions were derived, together with the corre-
sponding Boolean functions and their accuracy if these
simple functions are used for classiﬁcation on the EMBP
dataset. For convenience, these Boolean functions are also
formulated in words in Figure 3, where ‘‘presence’’ and
‘‘absence’’ of a gene refer, for simplicity, to the presence or
absence of mRNA from the gene. Furthermore, we found that
gene ENTPD1 in Figure 3B can be replaced by gene
HIST1H1E, and that gene NCF4 in Figure 3C can be replaced
by gene KRT6E. In both cases, these substitutions yield
identical results.
The genes mentioned in Figure 3 should not be seen as
individual ‘‘prostate cancer-related genes,’’ which, in tradi-
tional approaches, are found to be either consistently
overexpressed or consistently underexpressed in prostate
cancer. Instead, each of the identiﬁed genes should be seen as
a member of a synergistic gene module, as evidenced by the
formulation of the corresponding Boolean function. To
further clarify the fundamental difference between the two
approaches, we mention the following ‘‘notable facts’’ for
each of the ﬁve identiﬁed gene modules, derived from simple
observation of the counts in each Karnaugh map, each of
which could provide hints for its biological explanation:
(1) Absence of RBP1, if accompanied by either presence of
TMSL8 or absence of SPINK2, is associated with cancer in 50
out of 53 such tissues. However, in the simultaneous absence
of TMSL8 and presence of SPINK2, absence of RBP1 is not
Table 2. List of the Minimum Entropy Gene Modules for Different Thresholds
Threshold Gene Module Entropy
ab c
30 SPINK2 TMSL8 RBP1 0.19155
45 HPN ENTPD1 NELL2 0.14302
60 NCF4 HPN PGM1 0.11587
75 HPN MCM3AP GSTP1 0.16287
90 HLA-DQB1 FNBP1 DF 0.13267
DOI: 10.1371/journal.pcbi.0020068.t002
Table 3. List of Genes That Were Included in the Estimated Gene Modules along with Their Accession Numbers and Gene Description
Symbol Accession Number Alias/Description
COL4A6 D21337 Collagen, type IV, alpha 6
CYP1B1 U03688 Cytochrome P450, family 1, subfamily B, polypeptide 1
DF M84526 Adipsin, D component of complement
ENTPD1 AJ133133 Ectonucleoside triphosphate diphosphohydrolase 1
FNBP1 AB011126 KIAA0554, Formin binding protein 1
GSTP1 U12472 Glutathione S-transferase pi
HLA-DQB1 M81141 Major histocompatibility complex, class II, DQ beta 1
HPN X07732 Hepsin, transmembrane protease, serine 1
HIST1H1E M60748 H1F4, Histone 1, H1e
KRT6E L42611 Keratin 6E
MCM3AP AB011144 KIAA0572, MCM3 minichromosome maintenance deficient
3 (S. cerevisiae) associated protein
NCF4 AL008637 P40PHOX, neutrophil cytosolic factor 4 (derived from precise chip probe)
NELL2 D83018 NEL-like 2 (chicken) protein
PGM1 M83088 Phosphoglucomutase 1
RBP1 M11433 Cellular retinol binding protein 1
SERPINB5 U04313 Maspin, Serpin peptidase inhibitor, clade B (ovalbumin), member 5
SPINK2 X57655 Serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)
TMSL8 D82345 TMSNB, Thymosin-like 8
DOI: 10.1371/journal.pcbi.0020068.t003
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healthy.
(2) Presence of NELL2 is associated with health in 37 out of
39 such tissues, even if HPN (normally associated with cancer)
is present. Simultaneous presence of HPN and NELL2 is
associated with health in 17 out 19 such tissues.
(3) Presence of NCF4 is associated with health in all 11 such
tissues, even if HPN (normally associated with cancer) is
present: Simultaneous presence of HPN and NCF4 is
associated with health in all nine such tissues. The same
formulation is true if NCF4 is replaced by KRT6E.
(4) If either HPN is present or MCM3AP is absent, then the
absence of GSTP1 is associated with cancer, as all such 39
tissues are cancerous. However, if HPN is absent and
MCM3AP is present, then the absence of GSTP1 is not
associated with cancer, as all such nine tissues are healthy.
(5) In the absence of HLA-DQB1, absence of DF is associated
with cancer in 48 tissues out of 50, and presence of DF is
associated with health in 36 tissues out of 38. However, in the
presence of HLA-DQB1, absence of DF is instead associated
with health, as all 11 such tissues are healthy.
Validation of the gene modules and Boolean functions
using the validation dataset. Although the classiﬁcation
performance of the Boolean functions from EMBP analysis
is high over the dataset upon which the results were derived
(Figure 3), it is important to validate these results over
Figure 3. Karnaugh Maps Leading to Boolean Functions across Different Thresholds
Shown are the Karnaugh maps for the minimum entropy three-gene modules for five choices of binarization threshold, the parsimonious Boolean
functions derived from the Karnaugh maps, and the classification accuracy of these Boolean functions over the EMBP dataset. Furthermore, we found
that gene ENTPD1 in Figure 3B can be replaced by gene HIST1H1E and that gene NCF4 in Figure 3C can be replaced by gene KRT6E. In both cases, these
substitutions yield identical results, but are not shown in the figure, for simplicity.
DOI: 10.1371/journal.pcbi.0020068.g003
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gene modules of Figure 3 using their corresponding Boolean
functions on the ‘‘validation dataset’’ [11]. For that task, we
needed to binarize the expression levels of the validation
dataset.
Because of the simplicity of the Boolean functions shown in
Figure 3, which are applied to only three genes, any choice of
threshold for this task yielding good classiﬁcation results
would be remarkable, as a moment’s thought would be
convincing that a ‘‘random’’ Boolean function cannot have
good classiﬁcation results regardless of the threshold choice.
We chose, nevertheless, to ﬁnd a single transformation
formula mapping the EMBP dataset thresholds to the
validation dataset thresholds. This is not a straightforward
task, because of the lack of standardization in the conditions
involved when measurements are made in different labora-
tories. For example, in our case, the median intensity of the
validation dataset was close to ten times that of the EMBP
dataset.
We used a simple transformation of the form y ¼ ax þ b
where x represents thresholds over the EMBP dataset and y
represents thresholds over the validation dataset. To estimate
the coefﬁcients a and b, we averaged the gene expression
values over all tissues for the 12,600 genes common to both
datasets. We thus obtained two vectors x and y of length
12,600, whose elements were the mean gene expression levels
across all tissues belonging to the EMBP and validation
datasets, respectively. Using these two vectors, we calculated
the least-squares estimate for the coefﬁcients a and b. The
mean value and the 95% conﬁdence bound for the two
coefﬁcients were found to be: a ¼ 8.25 6 0.088 and b ¼ 92.12
6 9.06. We transformed the thresholds using several values of
a and b within the 95% conﬁdence bounds, and selected the
values yielding the highest found classiﬁcation performance,
which were a ¼ 8.338 and b ¼ 92.12. Table 4 summarizes the
results for each of the ﬁve Boolean functions outlined in
Figure 3 over the validation dataset.
Remarkably, the classiﬁcation accuracy of the simple three-
gene (two-gene in one case) Boolean functions in the
validation dataset were consistently high, exceeding 90% in
most cases, indicating that EMBP analysis accurately ex-
tracted universally valid prostate cancer–related features. By
comparison, the validation results of the k-nearest neighbor-
based classiﬁcation in [10], from which we extracted our
input data, using the same training and testing data [11], had
classiﬁcation accuracy of 77% for four-gene models and 86%
on 16-gene models, while even our worst accuracy across
different thresholds for three-gene classiﬁcation was 85.29%
(see Table 4).
As mentioned earlier, because of overﬁtting, the classiﬁca-
tion accuracy on the validation data would not increase had
we used four-gene modules for the threshold choices in Table
4. Indeed, the resulting Boolean functions were the same as
the Boolean functions for n¼3, since the Boolean Parsimony
procedure found that the fourth gene in the modules was
irrelevant. To illustrate the concept of overﬁtting, we also
evaluated the classiﬁcation performance of the four-gene
modules on the validation datasets by skipping the Boolean
Parsimony procedure, instead using the individual states of
the four-gene modules as predictors of cancer. In other
words, we predicted each state to be cancerous or benign
based on the ‘‘majority count’’ calculated from the values of
N0 and N1 in the training dataset. The classiﬁcation perform-
ance of the four-gene modules across thresholds 30, 45, 60, 75,
and 90 was found to be 85.29%, 94.11%, 91.17%, 82.35%, and
79.41% respectively. In other words, the performance of the
four-gene modules either worsens or remains the same
compared to the three-gene EMBP modules in Table 4. Thus
the Boolean Parsimony procedure addresses the problem of
overﬁtting by its very nature.
Biological Interpretation of EMBP Analysis Results
The genes in the modules resulting from EMBP analysis are
not co-regulated, because, if they were, then each of them
alone would provide much of the information that all of them
provide; therefore a different gene would be a more
appropriate partner, as it would provide complementary
information. Nevertheless, these genes are typically related by
as h a r e dc o m m o n‘‘theme’’ in which they are playing
synergistic roles. For example, two genes may appear because
they are both required for the activation of a particular
cancer-causing pathway. Of course, the cause-and-effect
relationship connecting disease and the presence of partic-
ular genes in a gene module is not clear from the results of
quantitative analysis alone, and the Boolean functions can
only be seen as approximations when they are based on a
relatively small set of input data, as in our case.
Coupled with additional biological knowledge, however,
the results of EMBP analysis can help infer disease-related
pathways, which, in turn can help develop therapeutic
interventions. This methodology uses the clues provided by
the results to create speculative assumptions involving addi-
tional genes. Assuming that each gene module has a ‘‘story’’ to
say, we can then attempt to combine all these ‘‘stories’’ into
Table 4. Classification Accuracy of EMBP Analysis Results over the Validation Dataset
EMBP Dataset
Threshold
Gene Module Boolean
Function
Validation
Dataset Threshold
Classification
Accuracy (%)
Specificity
(%)
Sensitivity
(%) ab c
30 SPINK2 TMSL8 RBP1 bc9 342.26 85.29 77.78 88
45 HPN ENTPD1 NELL2 ab9c9 467.33 94.12 100 92
60 NCF4 HPN PGM1 a9bc9 592.40 94.12 100 92
75 HPN MCM3AP GSTP1 a(c9 þ b9) 717.47 97.06 100 96
90 HLA-DQB1 FNBP1 DF a9b9c9 842.54 85.29 77.78 88
DOI: 10.1371/journal.pcbi.0020068.t004
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we provide two examples of this methodology.
We ﬁrst focus on the three-gene module with the lowest
overall conditional entropy (0.1159) (Figure 3C), consisting of
genes HPN, NCF4, and PGM1. Hepsin (HPN) is a serine
protease that is overexpressed in most prostate cancers [19].
Recent evidence indicates [20,21] that hepsin converts single-
chain pro-hepatocyte growth factor into biologically active
two-chain hepatocyte growth factor. The hepatocyte growth
factor (HGF) is a ligand for Met, a known proto-oncogene
receptor tyrosine kinase, suggesting [20,21] that this func-
tional link between hepsin and the HGF/Met pathway may be
related to tumor progression. Furthermore, HGF protects cell
against oxidative stress–induced apoptosis [22,23]. These
results suggest that hepsin may promote tumor progression
by inhibiting the apoptotic mechanisms that are normally
activated in cells after they become cancerous as a result of
damage caused by oxidative stress.
Interestingly, both of the other members of the module
(NCF4 and PGM1) have also been related to oxidative stress,
strengthening the above speculative interpretation. Phospho-
glucomutase is inhibited under oxidative stress [24]. The
absence of PGM1 (as in the Boolean function of Figure 3C)
could therefore result from oxidative stress. On the other
hand, NCF4, also known as P40PHOX, is known to down-
regulate [25,26], under some conditions, the NADPH oxidase,
a phagocyte enzyme system that creates a superoxide-
producing ‘‘oxidative burst’’ in response to invasive micro-
organisms. In this case, local oxidative stress would result
from the reduced levels of P40PHOX activity.
Taken together, the above observations suggest a spec-
ulative scenario consistent with the Boolean function of
Figure 3C: The absence of NCF4 (perhaps as a result of
mutation), if accompanied by other unknown factors, permits
activation of the NADPH oxidase, which could be aberrant,
i.e., not necessarily responding to the presence of invasive
microorganisms. If this happens, then the resulting oxidative
burst, evidenced by PGM1 down-regulation, is damaging to
the cell and is normally accompanied by triggering apoptotic
mechanisms, which, however, are inhibited by the activated
HGF resulting from the presence of hepsin. The damaged
surviving cell may then become cancerous as a result of
additional mutations. This interpretation may also shed light
on the problem of the ‘‘hepsin paradox’’ [27]: Although
hepsin is overexpressed in the vast majority of prostate
cancers and is thought to promote tumor progression, it is
unexpectedly underexpressed in metastatic lesions. It could
be that the additional mutations in the damaged cells have
already inactivated the apoptotic mechanisms, at which stage
the expression of hepsin is not needed anymore for the
‘‘protection’’ of the cell, and cancer becomes more invasive.
Furthermore, as noted above, the same conditional entropy
(0.1159) with the same Boolean function results if we replace
gene NCF4 with gene KRT6E (keratin 6E). It is known that
mutations in keratin genes can prime cells to oxidative injury
[28]. In that case, KRG6E is absent due to its mutation, and
the resulting oxidative injury is not stemming from NADPH
oxidation, but is still manifested by the absence of PGM1, and
the apoptotic mechanisms are still inhibited by the presence
of hepsin.
There are many more gene modules that are revealed by
EMBP analysis in addition to those indicated in Figure 3, and
their complete presentation and interpretation is beyond the
scope of this paper. We note, however, that the ‘‘theme’’ of
oxidative stress combined by inhibition of apoptosis is
encountered in several of them. Therefore, the credibility of
this speculative interpretation is strengthened, because it can
be consistently made multiple times with respect to other gene
modules. Conﬁrming the plausibility of this hypothesis,
independentstudieshavealsolinkedoxidativestresstoprostate
cancer [29]. Here we present one more such gene module that
we found, which is particularly relevant in that respect.
This module resulted from a threshold choice of 15. As
seen in Figure 2A, the conditional entropy of the optimum
three-gene module (shown outside the dotted box) is
relatively high, exceeding 0.3. Therefore, we found the
lowest-entropy four-gene module. The result is shown in
Figure 4, and is the one that we had also used to generate
Table 1 with corresponding minimum entropy of 0.088. Gene
ai sCOL4A6 (collagen type IV alpha 6), gene b is CYP1B1
(cytochrome P450, family 1, subfamily B, polypeptide 1), gene c is
SERPINB5 (maspin, or serpin peptidase inhibitor, clade B, member 5),
and gene d is GSTP1 (glutathione S-transferase pi). The most
parsimonious Boolean function containing the entries of the
Karnaugh map predominantly associated with cancer is
(bþd9)a9c9.
The meaning of this function is the following: Cancerous
tissues are associated with the absence of both COL4A6 and
SERPINB5 accompanied by either the presence of CYP1B1 or
absence of GSTP1. Figure 4 also shows the Boolean function
represented by a tree structure, which can be useful for
providing insight into the ﬂow of information in pathways
when the number of genes in a module is high.
The common theme in this cluster is easily detected by the
simultaneous presence of two genes, which have the following
Figure 4. Karnaugh Map and Tree Representation of the Most
Parsimonious Boolean Function for the Minimum Entropy Four-Gene
Module at Threshold ¼ 15
Cancerous tissues are associated with the absence of both COL4A6 and
SERPINB5 accompanied by either the presence of CYP1B1 or absence of
GSTP1.
DOI: 10.1371/journal.pcbi.0020068.g004
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Entropy Minimization and Boolean Parsimonyproducts: On the one hand, CYP1B1 is an oxidative enzyme
induced by, and metabolizing, various substances, several of
which are toxins, and on the other hand GSTP1 is another
enzyme whose role is to detoxify by catalyzing conjugation of
glutathione. Products of oxidative metabolism are ‘‘natural’’
substrates for the glutathione transferases [30]. Therefore,
consistent with the observation that CYP1B1 and GSTP1 are
coordinated in sequential reactions [31], it is reasonable to
assume that, in normal prostate tissues, part of the role of
GSTP1 is to respond to oxidative stress by detoxifying
procarcinogens that have been activated by oxidative
enzymes such as CYP1B1.
CYP1B1 has been found overexpressed and regulated by
promoter hypomethylation in prostate cancer [32] and several
cancer therapeutic options associated with CYP1B1 are under
consideration [33]. On the other hand, GSTP1 has been found
underexpressed in prostate cancer, often as a result of
hypermethylation of its regulatory sequences [34,35]. Inter-
estingly, there are three known gene variants of GSTP1, and
the gene variant (GSTP1*C) that we include in the Boolean
function is the one, among the three, that was shown to
contain functional retinoic acid response elements (RAREs) in
its introns, conﬁrmed by the observation that retinoic acid
treatment signiﬁcantly increased GSTP1*C gene expression in
glioblastoma cells, a fact that may contribute to a better
understanding of the molecular regulation of the GSTP1 gene
in human cells [36] and provide possibilities for therapeutic
intervention. We note that we have identiﬁed gene RBP1
(retinol binding protein 1) as a member of several of the gene
modules that we found (one of which also appears in Figure 3),
and it was recently hypothesized that the protective role of
RBP1 is due to inhibition of the PI3K/AKT survival pathway
through a retinoic acid receptor–dependent mechanism [37].
A third molecule in the module of Figure 4 is SERPINB5, or
maspin, a serine protease inhibitor. Its product has been
identiﬁed as a tumor suppressor, originally in breast cancer
[38]. The absence of its expression has also been linked to
promoter methylation [39]. Given the identiﬁed theme of the
gene module, we would like to see in what ways maspin is
related to oxidative stress. Strikingly, precisely this role has
recently been proposed for maspin in prostate cancer tissues
[40]: that maspin may inhibit oxidative stress–induced
generation of reactive oxygen species (such as free radicals)
by interacting with glutathione S-transferase, thus preventing
adverse effects on tumor genetics. This hypothesis is
consistent with the entries of Figure 4, indicating that a
combination of GSTP1 and SERPINB5, and not GSTP1 alone,
as noted earlier, is needed to counteract the expression of
CYP1B1. Indeed, although all 13 tissues associated with state
0101 are cancerous (N0 ¼ 0 and N1 ¼ 13), all ﬁve tissues
associated with state 1111, in which maspin is expressed in
addition to GSTP1, are healthy (N0 ¼ 5 and N1 ¼ 0).
More speciﬁcally, maspin was found to interact with three
molecules: The two molecules in addition to glutathione S-
transferase were two ‘‘stress proteins’’ (heat shock proteins
HSP70 and HSP90), suggesting that intracellular maspin may
be primarily involved in cellular response to stress stimuli
[40] by inducing apoptosis [41]. Furthermore, heat shock
proteins are known to be induced by oxidative stress and they
m a yp l a yo n c o g e n i cr o l e sb y‘‘protecting’’ cells from
apoptosis. For example, it has been found that reactive
oxygen species play important roles in the activation of HSF1
(heat shock factor 1, the primary transcription factor
responsible for the transcriptional heat stress response in
mammalian cells) and in the accumulation of mRNA of the
previously mentioned genes HSP70 and HSP90 in the
ischemic-reperfused heart [42].
From the observations so far, it follows that GSTP1 and
maspin may work synergistically to counteract oxidative
stress, perhaps by maspin inducing apoptosis whenever
GSTP1-induced detoxiﬁcation is not successful. Interestingly,
maspin, a serine protease inhibitor, and hepsin, a serine
protease that we previously speculated to play an apoptosis-
inhibitive role, were found to be inversely expressed in
prostate cancer [43]. Even without the presence of CYP1B1,
the simultaneous absence of both GSTP1 and maspin appears
to be sufﬁcient to cause cancer, as indicated by the entries at
states 0000 and 0100 in Figure 4.
The only remaining gene in that module is COL4A6, which
encodes one of the six subunits of type IV collagen, the major
structural component of basement membranes. The associ-
ation that we found, using EMBP analysis, between COL4A6
and prostate cancer is remarkable, because COL4A6 expres-
sion is missing in nearly all cancerous tissues as evidenced by
the Boolean function. This absence of COL4A6 expression in
prostate cancer has also been observed before [44].
There are two identiﬁed splice variants of COL4A6: splice
variant A and splice variant B, each of which uses a distinct
promoter [45]. The speciﬁc gene in our microarray data is
splice variant B. It was recently found [46] that splice variant
B is regulated by HSF1 (heat shock factor 1, mentioned
earlier) [42]. Speciﬁcally, HSF1 binding was detected at the
promoter of splice variant B [46], suggesting that COL4A6
plays a novel role in the heat shock response. Therefore, the
possibility exists that one promoter confers tissue speciﬁcity
for COL4A6’s role in the basement membrane and the other
promoter regulates the gene for its potentially novel role [46].
This novel role is unclear, but collagen IV has already been
found to regulate pathways related to oxidative stress through
ERK activation [47,48].
Together with the fact, noted earlier, that maspin interacts
with HSP70 and HSP90, these observations further strengthen
the case that the gene module is related to oxidative stress
including heat shock–related stress. Interestingly, HSP70 has
been found [49] overexpressed in some prostate cancers and
in the plasma levels in prostate cancer patients [50].
Therefore, a plausible speculative scenario for this module
is the following: CYP1B1 expression is induced by some toxins
and, at least in some CYP1B1 polymorphisms [51], they are
activated and contribute to a type of cancer-causing oxidative
stress. This oncogenic effect can be countered by the
expression of GSTP1 and maspin, resulting in either detox-
iﬁcation or apoptosis. In particular, absence of maspin may
inhibit the apoptotic mechanisms normally activated in these
cases. The role of the prominent observed down-regulation of
COL4A6 in the cancerous tissues is unclear, but it may be
related to the activation of the heat shock response as a result
of the oxidative stress, and it may indicate that collagen plays
an important and yet unrecognized role in prostate cancer.
Discussion
The most notable feature of the EMBP method is that it is
systems-based, in the sense that it considers the synergistic
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or sets of co-regulated genes as in microarray clustering
techniques. As a result, the optimal gene module of size n 1
may not be a subset of the optimal gene module of size n,
because the n members of the latter module may interact
synergistically toward predicting disease in a manner that
cannot be achieved if any one of the n members is removed.
EMBP analysis actually discovers such gene modules mecha-
nistically, and can therefore complement other gene-set–
based techniques, such as ‘‘Gene Set Enrichment Analysis’’
[4], in which the gene sets are deﬁned based on prior
knowledge, such as published information about biochemical
pathways.
Discrimination between healthy and diseased tissues, or
between different types of diseases, is not the main purpose
of EMBP analysis, although it can be used for this task. If we
wanted to focus on classiﬁcation, then we would use many
genes, connect their expression levels in sophisticated ways,
rather than through one extremely simple Boolean function,
and use their continuous expression levels instead of binar-
izing them, so that we can extract additional information.
Nevertheless, we still validated our results for classiﬁcation
accuracy using the binarized data from sets of three genes
connected by simple Boolean functions, applied on totally
new microarray data, independently generated in a different
lab. The resulting high classiﬁcation accuracy of typically
more than 90% (Table 4), conﬁrms that the extracted logic
function connecting these genes is valid in the testing set as
well, and therefore it is likely to be a universal property in
prostate cancer tissues. In particular, the ‘‘notable facts,’’
mentioned earlier, resulting from our Boolean functions,
indicate a precise functional relationship among the genes
leading to disease, which is valid on both the training and the
testing datasets.
We tested the effect of sample size on the results by
performing EMBP analysis on several randomly selected
subsets of the training data using equal numbers (10, 20, 30,
and 40) of samples from normal and cancerous tissues. The
minimum entropy results are shown in Figure 5. We observe
that the average minimum entropy values for n¼1, 2, 3, and 4
increase with the number of samples. Furthermore, it is also
seen that for lower number of samples, the entropy reaches
zero for lower values of n when compared with higher sample
datasets. However, the entropy values appear to increase at a
low rate as n becomes close to 50. Thus, we expect that for
prostate cancer analysis, having more than a 100 samples
from each category would not add additional information.
As mentioned earlier, the genes in the modules from EMBP
analysis are not co-regulated, but they are co-operative. This
is in sharp contrast to the gene modules resulting from
clustering or bi-clustering approaches [52–58], the very
nature of which is to cluster genes with similar expression
patterns. Several of these clustering approaches use entropy
extremization and other information theoretic measures, but
in totally different contexts compared with our purposes.
For example, in reference [56], entropy minimization is
used to reduce the amount of ‘‘disorder’’ within each cluster
so that data points within a cluster are similar to each other.
In reference [57], the mutual information between different
clusters is minimized so that expression proﬁles falling into
different clusters are maximally different from each other. In
reference [58], pairwise mutual information is maximized to
cluster genes together so that the genes within each cluster
have maximum relevance with each other. In all such
clustering approaches, the principal strategy is to cluster
together genes that have similar expression levels given a
particular phenotype. In contrast, the genes within an EMBP
module are chosen such that we minimize the uncertainty of
assigning correct phenotype labels from the joint expression
values of the genes in that module. Thus the genes within the
EMBP gene set can have very different expression patterns
given the phenotype.
We believe that EMBP analysis provides an opportunity for
fruitful cross-disciplinary collaboration in which biologists
use the ‘‘clues’’ resulting from the computational results to
infer potential pathways, which they can validate with genetic
experiments, as well as suggest further computational experi-
ments. For example, if we wish to identify which genes play
synergistic roles with another particular gene in terms of
causing disease, we could ‘‘freeze’’ the presence of that gene
and identify the other genes in a module minimizing the
entropy. Furthermore, our systems-based approach can
immediately suggest novel potential therapeutic methods
that would not be possible with traditional individual-gene
approaches, for example, targeting simultaneously two genes
that appear in the same Boolean function by combining two
already existing drugs targeting each of these genes.
We hope that EMBP analysis will prove to be a signiﬁcant
new tool for medical research working synergistically with the
future efforts of diseased tissue genome sequencing. To
illustrate with an example, if a Boolean function a9b9c9 is
found when analyzing expression data of a particular cancer,
thiswould suggestthe possibility that thethree genes ‘‘genea,’’
‘‘gene b,’’ and ‘‘gene c’’ may cause cancer when all are
inactivated, perhaps due to their mutation or to hyper-
methylation of their promoter, as we previously discussed
regarding KRT6E and GSTP1. In turn, this observation may
provide motivation to sequence these genes in cancerous
Figure 5. Minimum Entropy Values Averaged over Four Trials across
Different Sample Sizes for Threshold ¼ 15
The minimum entropy values increase with sample size for any given n,
but they tend to saturate for large numbers of samples.
DOI: 10.1371/journal.pcbi.0020068.g005
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Entropy Minimization and Boolean Parsimonytissues. For EMBP analysis to be signiﬁcantly effective, in
addition to diseased tissues, hundreds of healthy tissues must
also be proﬁled for each tissue type. Inclusion of data from
healthy tissues has so far not been emphasized, mainly because
microarray data were thought to be more useful for classifying
among disease subtypes, rather than detecting disease from
non-disease, which is often achievable by normal biopsies.
Furthermore, it is important to use large and high-quality
input datasets obtained under standardized conditions.
Materials and Methods
Entropy minimization. We used a combination of two heuristic
optimization techniques to search for minimum entropy gene sets,
allowing sufﬁcient time for each of them to converge. The ﬁrst
technique is the following: Starting from a randomly chosen gene set
of size n, at each step of the iteration, we modify the ‘‘current’’ gene
set by replacing one of its genes, chosen at random, with a new gene,
also chosen at random from the entire gene set M. If the conditional
entropy of the new gene set is lower than that of the current gene set,
then the new gene set replaces the current gene set. The process
terminates when the conditional entropy is 0, or when the current
gene set remains unmodiﬁed for a particular large number of steps.
To avoid selecting a local minimum, we repeat the same iterative
algorithm several times, starting from different initial conditions of
the same size, and select the gene set that yields the overall lowest
conditional entropy. We then increase the size of the gene set to nþ1
and repeat the whole process, making sure that one of the chosen
initial conditions contains the previously found gene set. This
technique typically converges to some choice of near-optimum
results.
To reduce the chance that the found solution corresponds to a
local, rather than global minimum, we also used simulated annealing
[59] to search in the space of all subsets of size n.I na n‘‘annealing’’
process, a melt, initially disordered and at high ‘‘temperature’’ T, is
slowly cooled. As cooling proceeds, the system becomes more ordered
and approaches a ‘‘frozen’’ state at T¼0. In our case, we started from
a randomly chosen gene set of size n and replaced a randomly chosen
gene in the set by another randomly chosen gene from the entire set
of M genes. If the conditional entropy of the new gene set is found to
be lower than that of the current gene set, we replace the current set
with the new set. If, however, the conditional entropy of the new gene
set is higher than that of the current gene set, we allow replacement
of the current gene set with a probability p—accept that is proportional
to the temperature Tk at the time and inversely proportional to the
amount by which the conditional entropy of the new gene set is
higher than that of the current gene set. Thus, the value of p—accept at
any given temperature Tk is given by:
p acceptðTk;dHÞ¼exp  
dH
Tk
  
ð5Þ
where dH is the increase in conditional entropy due to the random
change in the gene set.
The parameters of the simulated annealing algorithm that we used
were:
p init ¼ 0:3 ð6Þ
which is the initialization value of p—accept),
T init ¼
 hdHi
logeðp initÞ
ð7Þ
where hdHi is the average increase in conditional entropy due to a
random change in a gene set,
Lk ¼ 1;500 ð8Þ
which is the total number of transitions at the k
th temperature,
gmin ¼ 500 ð9Þ
which is the minimum number of acceptances at the k
th temperature,
and
kmax ¼ 1;000 ð10Þ
which is the total number of temperature values to be tried over the
course of the algorithm.
The ‘‘cooling scheme’’ deﬁnes the rate at which the temperature
falls over the length of the algorithm. We adopted the exponential
cooling scheme deﬁned as Tkþ1 ¼ aTk, where a ¼ 0.98. The simulated
annealing algorithm allows for signiﬁcant increases in the conditional
entropy at higher temperatures, searching coarsely in the space of
subsets of genes. As the temperature falls, the probability of accepting
even small increases in conditional entropy is reduced, thus searching
only in the local neighborhood of the conditional entropy value.
An average run of the simulated annealing algorithm for
estimating the minimum conditional entropy gene-set for n ¼ 3, on
a Pentium III processor running at 3 GHz is around 30 min.
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